Skip to main content
SpringerLink
Log in

Validity and reliability of a checklist for patients with Behçet’s disease based on the International Classification of Functioning, Disability and Health

  • Validation Studies
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

In 2020, we reported the “BD-checklist 92” for patients with Behçet’s disease (BD) based on the International Classification of Functioning, Disability and Health. The purpose of the present study was to evaluate the validity and reliability of this checklist. Questionnaires using the “BD-checklist 92” and the 36-item Short Form Survey (SF-36) were sent to ten affiliated institutions. In total, 174 patients answered the questionnaire (response rate, 32.7%). Criterion validity was evaluated using the correlation coefficient between the number of problem categories extracted from the “BD-checklist 92” and the scores of the eight subscales and two components of the SF-36. Construct validity was assessed based on the number of problem categories extracted as an external criterion for the number of manifestations experienced and specific lesions. The comparison was performed using the Mann–Whitney U test. Cronbach’s alpha coefficient was used to evaluate reliability. The number of problem categories in the “Body functions and structures”, “Activities and participation”, and “Environmental factors” components correlated significantly with all dimensions of the SF-36 questionnaire (P < 0.05 each). Construct validity showed that the number of manifestations experienced in all components (P < 0.001 each) and specific lesions in “Body functions and structures” and “All categories” (P = 0.002 and 0.050, respectively) contributed to an increased number of problems associated with BD. Cronbach’s alpha coefficient for the “BD-checklist 92” was 0.926. This study confirmed the validity and reliability of the “BD-checklist 92”.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet’s disease. N Engl J Med 341:1284–1291. https://doi.org/10.1056/NEJM199910213411707

    Article  CAS  PubMed  Google Scholar 

  2. Ministry of Health, Labour and Welfare (2021) Report on Public Health Administration and Services FY2019. https://www.e-stat.go.jp/stat-search/files?page=1&layout=datalist&toukei=00450027&tstat=000001031469&cycle=8&tclass1=000001148807&tclass2=000001148808&tclass3=000001148810&cycle_facet=tclass1%3Atclass2%3Atclass3%3Acycle&tclass4val=0. Accessed 28 Mar 2021 (in Japanese)

  3. Bhakta BB, Brennan P, James TE, Chamberlain MA, Noble BA, Silman AJ (1999) Behçet’s disease: evaluation of a new instrument to measure clinical activity. Rheumatology 38:728–733. https://doi.org/10.1093/rheumatology/38.8.728

    Article  CAS  PubMed  Google Scholar 

  4. Tsutsui H, Kikuchi H, Oguchi H, Nomura K, Ohkubo T (2020) Identification of physical and psychosocial problems based on symptoms in patients with Behçet’s disease. Rheumatol Int 40:81–89. https://doi.org/10.1007/s00296-019-04488-1

    Article  PubMed  Google Scholar 

  5. Japan Intractable Diseases Information Center (2020) Behçet’s disease (Designated intractable disease 56). https://www.nanbyou.or.jp/entry/330. Accessed 16 Jul 2021 (in Japanese)

  6. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483

    Article  Google Scholar 

  7. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K (1998) Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 51:1037–1044. https://doi.org/10.1016/s0895-4356(98)00095-x

    Article  CAS  PubMed  Google Scholar 

  8. Fukuhara S, Ware JE Jr, Kosinski M, Wada S, Gandek B (1998) Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol 51:1045–1053. https://doi.org/10.1016/s0895-4356(98)00096-1

    Article  CAS  PubMed  Google Scholar 

  9. Khabbazi A, Ebrahimzadeh Attari V, Asghari Jafarabadi M, Malek MA (2021) Quality of life in patients with Behçet disease and its relation with clinical symptoms and disease activity. Reumatol Clin 17:1–6. https://doi.org/10.1016/j.reuma.2019.03.002

    Article  PubMed  Google Scholar 

  10. Aflaki E, Farahangiz S, Salehi A (2020) Quality of life assessment in patients with Behçet’s disease using the Persian version of the Leeds BD-QoL questionnaire. Iran J Med Sci 45:352–358

    PubMed  Google Scholar 

  11. Bernabé E, Marcenes W, Mather J, Phillips C, Fortune F (2010) Impact of Behçet’s syndrome on health-related quality of life: influence of the type and number of symptoms. Rheumatology (Oxford) 49:2165–2171. https://doi.org/10.30476/ijms.2020.72634.0

    Article  Google Scholar 

  12. Kuzu Kumcu M, Bakırarar B, Yücesan C (2021) Quality of life in neuro-Behçet’s disease: a cross-sectional study. Neurol Sci 42:1081–1086. https://doi.org/10.1007/s10072-020-04630-z

    Article  PubMed  Google Scholar 

  13. Gorial FI, Jabbar MA (2020) Impact of disease activity on health related quality of life in patients with Behçet’s disease: a cross-sectional study. Ann Med Surg (Lond) 54:43–46. https://doi.org/10.1016/j.amsu.2020.03.010

    Article  Google Scholar 

  14. Taylor J, Glenny AM, Walsh T et al (2014) Interventions for the management of oral ulcers in Behçet’s disease. Cochrane Database Syst Rev 25:CD011018. https://doi.org/10.1002/14651858.CD011018.pub2

    Article  Google Scholar 

  15. Scherrer MAR, Rocha VB, Garcia LC (2017) Behçet’s disease: review with emphasis on dermatological aspects. An Bras Dermatol 92:452–464. https://doi.org/10.1590/abd1806-4841.20177359

    Article  PubMed  PubMed Central  Google Scholar 

  16. Zhang J, Tang Y, Yue S et al (2019) A review of Behçet’s disease from the perspectives of both Western and Chinese medicine. J Tradit Chin Med 39:139–152

    PubMed  Google Scholar 

  17. Ksiaa I, Abroug N, Kechida M et al (2019) Eye and Behçet’s disease. J Fr Ophtalmol 42:e133–e146

    Article  CAS  Google Scholar 

  18. Leccese P, Ozguler Y, Christensen R et al (2019) Management of skin, mucosa and joint involvement of Behçet’s syndrome: a systematic review for update of the EULAR recommendations for the management of Behçet’s syndrome. Semin Arthritis Rheum 48:752–762. https://doi.org/10.1016/j.semarthrit.2018.05.008

    Article  PubMed  Google Scholar 

  19. Vaiopoulos AG, Kapsimali V, Kanakis MA et al (2019) The frequency of arthritis in Adamantiades-Behçet’s disease in Greek patients. J Eur Acad Dermatol Venereol 33:416–420. https://doi.org/10.1111/jdv.15326

    Article  CAS  PubMed  Google Scholar 

  20. Ilhan B, Can M, Alibaz-Oner F et al (2018) Fatigue in patients with Behçet’s syndrome: relationship with quality of life, depression, anxiety, disability and disease activity. Int J Rheum Dis 21:2139–2145. https://doi.org/10.1111/1756-185X.12839

    Article  CAS  PubMed  Google Scholar 

  21. Hirohata S, Kikuchi H (2003) Behçet’s disease. Arthritis Res Ther 5:139–146. https://doi.org/10.1186/ar757

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Hirohata S (2015) Neurological involvement. In: Ishigatsubo Y (ed) Behçet’s disease. From genetics to therapies. Springer Japan, Tokyo, pp 101–116

    Google Scholar 

  23. Takeno M, Ideguchi H, Suda A, Kamiyama R, Ishigatsubo Y (2015) Vascular involvement of Behçet’s disease. In: Ishigatsubo Y (ed) Behçet’s disease. From genetics to therapies. Springer Japan, Tokyo, pp 79–100

    Google Scholar 

  24. Nagahori M (2015) Gastrointestinal involvement. In: Ishigatsubo Y (ed) Behçet’s disease. From genetics to therapies. Springer Japan, Tokyo, pp 117–127

    Google Scholar 

  25. Ye JF, Guan JL (2019) Differentiation between intestinal Behçet’s disease and Crohn’s disease based on endoscopy. Turk J Med Sci 49:42–49. https://doi.org/10.3906/sag-1807-67

    Article  PubMed  PubMed Central  Google Scholar 

  26. Choi HJ, Seo MR, Ryu HJ, Baek HJ (2015) Cross-cultural adaptation and validation of the Behcet’s disease current activity form in Korea. Korean J Intern Med 30:714–718. https://doi.org/10.3904/kjim.2015.30.5.714

    Article  PubMed  PubMed Central  Google Scholar 

  27. Guloksuz S, Wichers M, Kenis G et al (2013) Depressive symptoms in Crohn’s disease: relationship with immune activation and tryptophan availability. PLoS ONE 8:e60435. https://doi.org/10.1371/journal.pone.0060435

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Tomazoni EI, Benvegnú DM (2018) Symptoms of anxiety and depression, and quality of life of patients with Crohn’s disease. Arq Gastroenterol 55:148–153. https://doi.org/10.1590/S0004-2803.201800000-26

    Article  PubMed  Google Scholar 

  29. Markland AD, Jelovsek JE, Rahn DD et al (2017) Irritable bowel syndrome and quality of life in women with fecal incontinence. Female Pelvic Med Reconstr Surg 23:179–183. https://doi.org/10.1097/SPV.0000000000000358

    Article  PubMed  PubMed Central  Google Scholar 

  30. Ozer M, Bengi G, Colak R, Cengiz O, Akpinar H (2020) Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life. Medicine (Baltimore) 99:e20067. https://doi.org/10.1097/MD.0000000000020067

    Article  Google Scholar 

Download references

Acknowledgements

This study was supported by JSPS KAKENHI Grant Number 16K04187. The authors would like to thank Associate Professor Y. Kirino from the Department of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine; Associate Professor H. Nagafuchi from the Departments of Rheumatology and Allergy, St. Marianna University School of Medicine; Clinical Associate Professor K. Namba from the Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University; Professor T. Sawada from the Department of Rheumatology, Tokyo Medical University; Clinical Associate Professor T. Tono from the Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine; Professor K. Nakamura from the Department of Dermatology, Saitama Medical University; Professor N. Kitaichi from the Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University; Visiting Professor S. Hirohata from the Division of Rheumatology and Allergy, Department of Internal Medicine, Teikyo University School of Medicine; and Health and Labour Sciences Research Grants (Research on Intractable Diseases) from the Ministry of Health, Labour and Welfare of Japan, for their support with respect to the mail survey.

Funding

This study was supported by JSPS KAKENHI Grant Number 16K04187.

Author information

Authors and Affiliations

  1. Department of Hygiene and Public Health, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605, Japan

    Hideyo Tsutsui & Takayoshi Ohkubo

  2. Faculty of Rehabilitation and Care, Seijoh University, 2-172 Fukinodai, Tokai-City, Aichi, 476-8588, Japan

    Hideyo Tsutsui

  3. Division of Rheumatology and Allergy, Department of Internal Medicine, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605, Japan

    Hirotoshi Kikuchi, Hiroko Oguchi & Hajime Kono

Authors
  1. Hideyo Tsutsui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hirotoshi Kikuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroko Oguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hajime Kono
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Takayoshi Ohkubo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hideyo Tsutsui.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tsutsui, H., Kikuchi, H., Oguchi, H. et al. Validity and reliability of a checklist for patients with Behçet’s disease based on the International Classification of Functioning, Disability and Health. Rheumatol Int 42, 159–165 (2022). https://doi.org/10.1007/s00296-021-05001-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-021-05001-3

Keywords

Search

Navigation